Given that GLP-1 therapy builds gradually, each weeks delay can blunt patient enthusiasm and worsen clinical inertia
Theyre supported by years of data, regulated by the FDA, and often covered by insurance
By 2024, an estimated 12% of American adults reported taking a GLP-1 medication for diabetes, weight loss, or heart disease, according to data from the Kaiser Family Foundation
Conditions such as type 2 diabetes, hypertension, sleep apnea, and cardiovascular disease can make someone a better candidate for these medications
5.3 The "Tregs-Microglia-Neuron/NPCs" axis and GLP-1R/cAMP/PKA/IL-10 mediated immunosuppressive and neuroprotective effects of GLP-1RAs in ischemic stroke In summary, in the pathological state of ischemic stroke, T cells preferentially migrated to the lesion boundary, and significantly increased after ischemia, peaking in the following weeks and persisting for several months (71)